Drawing for EVOTEC OAI

USPTO serial 76309314

EVOTEC OAI

Reviewed by CopyMark Law Group

Reg. 2965462Status 710
Filing date
Status date
Registration date
Jul 12, 2005
Examiner
MCMORROW, RONALD G
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EVOTEC OAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for commercial and scientific purposes, namely, biologically active proteins and nucleic acids for clinical or pre-clinical research use, reagents and assay kits comprised of reagents, chemicals and buffers for biotechnological and chemical research; chemical substances used in the fresh-keeping and preservation of foodstuffsSECTION 8 - CANCELLED—
005Pharmaceutical preparations for use in the treatment of neurological, neuropathological diseases, cellular dysfunctions, tumors, vascular diseases, cancer, allergic diseases, metabolic diseases, genetic diseases, immunological diseases, cardiovascular diseases, inflammatory diseases, and viral and bacterial infections; veterinary preparations for use in the treatment of neurological, neuropathological diseases, tumors, vascular diseases, cellular dysfunctions, tumors, vascular diseases, cancer, allergic diseases, metabolic diseases, genetic diseases, immunological diseases, cardiovascular diseases, inflammatory diseases, and viral and bacterial infections, in livestock, domestic pets, and wild animals; sanitary preparations, namely, antibacterial handwash, antiseptics, general purpose germicide, sanitizers for hospitals or households; rodenticles and fungicide for agricultural and domestic use; herbicides for agricultural and domestic use; and reagents and assay kits comprised of reagents such as chemicals and buffers for medical diagnostic useSECTION 8 - CANCELLED—
009Scientific apparatus and instruments, namely, sample supports, pipettes, dispensing devices such as micro-dispenser devices for micro-fluidic systems, pipettes, nano-pipettes, optical instruments such as microscopes, spectrometers for use as laboratory equipment for research and industrial use in the fields of biotechnology, pharmaceuticals, medicine, diagnostics and chemistry including relations thereof to other subjects, such as information technology; scientific apparatus and instruments, namely, microscopes, screening devices, devices for chemical synthesis for the development and preparation of biotechnological, pharmaceutical and diagnostic products and methods; data carriers such as CCs, diskettes, tapes containing computer programs for use in commercial research and development and scientific research; and computer programs for the evaluation of experimental data in the field of pharmaceutical, biochemical, diagnostic and agrochemical fieldsSECTION 8 - CANCELLED—
016Printed materials, namely, instruction manuals for scientific apparatus and instruments, namely, sample supports, pipettes, dispensing devices such as micro-dispenser devices for micro-fluidic systems, pipettes, nano-pipettes, optical instruments such as microscopes, spectrometers for use as laboratory equipment for research and industrial use in the fields of biotechnology, pharmaceuticals, medicine, diagnostics and chemistry including relations thereof to other subjects such as information technology, scientific apparatus and instruments, namely, microscopes, screening devices, devices for chemical synthesis for the development and preparation of biotechnological, pharmaceutical and diagnostic products and methodsSECTION 8 - CANCELLED—
040Custom manufacture of chemicals used in industry, pharmaceuticals, science, agriculture, horticulture and forestry for othersSECTION 8 - CANCELLED—
042Research and development of new technology for others in the fields of biotechnology, pharmaceuticals, medicine, diagnostics, chemistry and information technology, software development, development of new technology for others in the field of evolutive optimization methods, and technical consultation in the fields of biotechnological, pharmaceutical, medicinal, diagnostic and chemical research and developmentSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)—
Nov 25, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Jul 12, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 19, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2005NPUBNOTICE OF PUBLICATION—
Jan 24, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2005ALIEASSIGNED TO LIE—
Jan 11, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 30, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 27, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 7, 2004CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 23, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 7, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2004MAILPAPER RECEIVED—
Aug 16, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Feb 6, 2004CNSLLETTER OF SUSPENSION MAILED—
Dec 24, 2003CFITCASE FILE IN TICRS—
Nov 19, 2003MAILPAPER RECEIVED—
Nov 17, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Oct 25, 2002CNSLLETTER OF SUSPENSION MAILED—
Oct 17, 2002DOCKASSIGNED TO EXAMINER—
Sep 23, 2002CNEAEXAMINERS AMENDMENT MAILED—
May 23, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance